Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?-Reference-Cited by-同舟云学术

Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?

Published:2012-07 Issue:7 Volume:12 Page:869-875
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Sacco Rodolfo,Bargellini Irene,Ginanni Barbara,Bertini Marco,Faggioni Lorenzo,Federici Graziana,Romano Antonio,Bertoni Michele,Metrangolo Salvatore,Altomare Emanuele,Parisi Giuseppe,Tumino Emanuele,Scaramuzzino Antonio,Bresci Giampaolo,Bartolozzi Carlo

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/era.12.58

Reference16 articles.

1. Global Cancer Statistics, 2002

2. Management of hepatocellular carcinoma: An update

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

5. From Randomized Controlled Trials to Observational Studies

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Tumor Radiomic Model for Identifying Extrahepatic Metastasis of Hepatocellular Carcinoma Based on Contrast Enhanced Computed Tomography;Diagnostics;2022-12-29

2. Safety and Effectiveness of Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma;Current Cancer Therapy Reviews;2022-05

3. Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma;Immuno;2022-02-15

4. Towards a tailored systemic therapy for liver cancer;Annals of Translational Medicine;2020-10

5. Organic anion transport polypeptide 1b2 selectively affects the pharmacokinetic interaction between paclitaxel and sorafenib in rats;Biochemical Pharmacology;2019-11